|
| United States Dollars
Year ended |
|
|
|
|
|
|
|
|
|
|
| |
| Net profit attributable to owners of the parent |
723.0 |
|
161.6 |
|
| Loss/(profit) on disposal of assets |
0.2 |
|
(1.2) |
|
| Taxation effect on disposal of assets |
(0.1) |
|
0.4 |
|
| Profit on disposal of Maverix1 |
– |
|
(33.8) |
|
| (Reversal of impairment)/impairment of FSE |
(62.3) |
|
9.6 |
|
| Impairment of investments and assets and other2 |
78.1 |
|
35.1 |
|
| Taxation on impairment of investments and assets2 |
(8.9) |
|
(9.0) |
|
| Non-controlling interest effect on impairment of investments and assets |
(0.7) |
|
– |
|
| Headline earnings |
729.3 |
|
162.7 |
|
| Headline earnings per share – cents |
83 |
|
20 |
|
| Based on headline earnings as given above divided by 878,661,474 (December 2019 – 827,386,603) being the weighted average number of ordinary shares in issue. |
|
|
| |
